2m 2m 2m 2m 2m 2m 2m
FORTRESS BIOTCH (FBIO)
NASDAQ
$2.89+$0.01 (+0.52%)
Price as of Aug 21, 2026 7:30 PM EDT- $95.7MMarket Cap
- 26.43%1-Year Change
- BiotechnologyIndustry
FORTRESS BIOTCH (FBIO)
$2.89+$0.01 (+0.52%)
FBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.87 | ||
Change | +$0.10 (+3.61%) | ||
Open | $2.80 | ||
High | $2.88 | ||
Low | $2.79 | ||
Previous Close | $2.77 | ||
Volume | 202,715 | ||
30-Day Average Volume | 697,454 | ||
1-Week Change | -2.05% | ||
1-Month Change | -18.70% | ||
1-Year Change | 26.43% | ||
3-Year Change | -57.82% | ||
5-Year Change | -93.75% | ||
Fundamentals | |||
Shares Outstanding | 33.4M | ||
Total Assets | $316.7M | ||
Market Cap | $95.7M | ||
Enterprise Value | -$61.3M | ||
Period: QTR TTM FY | |||
Revenue | $18.7M | ||
Net Income | -$468,000.00 | ||
Free Cash Flow | -$59.3M | ||
EBIT | $1.3M | ||
EBITDA | $2.3M | ||
Net Working Capital | $183.5M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | -3 | ||
P/B | 1 | ||
P/E | -36 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 10/10/2023 | ||
Earnings & Revenue